Skip to main content
RESONANCE HEALTH LIMITED logo

RESONANCE HEALTH LIMITED — Investor Relations & Filings

Ticker · RHT ISIN · AU000000RHT2 ASX Professional, scientific and technical activities
Open in API
Filings indexed 772 across all filing types
Latest filing 2026-05-26 Director's Dealing
Country AU Australia
Listing ASX RHT

About RESONANCE HEALTH LIMITED

https://www.resonancehealth.com/

Resonance Health Limited specializes in the development and commercialization of non-invasive medical imaging software and services. The company provides quantitative analysis of MRI scans to assist in the diagnosis and management of chronic diseases. Its flagship product, FerriScan, is an internationally recognized standard for measuring liver iron concentration (LIC). Other key offerings include HepaFat-Scan for liver fat assessment, Cardiac-T2* for cardiac iron measurement, and FerriSmart, an artificial intelligence-driven tool for rapid iron quantification. These technologies serve clinicians and pharmaceutical companies, particularly in clinical trials for iron overload disorders and non-alcoholic fatty liver disease. The company’s solutions are characterized by high precision and regulatory approvals from major global health authorities, offering a non-invasive alternative to traditional tissue biopsies.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - Dr David Fuller 2 pages 48.7KB
Director's Dealing Classification · 9% confidence The document is ASX Appendix 3Y, titled “Change of Director's Interest Notice,” detailing a director’s acquisition of shares, registered holdings before and after change, and compliance under listing rule 3.19A.2. This is a standard insider transaction/disclosure of director share dealings, matching the “Director’s Dealing” category.
2026-05-26 English
Profit Guidance Upgrade 3 pages 254.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 5 May 2026 from Resonance Health Limited providing an upgrade to its FY26 profit guidance, specifically underlying EBITDA and revenue expectations. It discusses operational performance, margin expansion, and outlook for the financial year ending 30 June 2026. The content is focused on updated financial guidance rather than full financial statements or detailed quarterly results. It is not a full annual or interim report, nor a detailed earnings release with key highlights only. The document is longer than 5,000 characters and contains substantive financial guidance updates, but it is primarily a capital/financing update related to profit guidance rather than a full financial report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-05-04 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 1.4MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities & Cashflow Report' and includes detailed financial data such as cash receipts, operating cash inflow, cash at bank, bank debt, and a consolidated statement of cash flows for the quarter ended 31 March 2026. It also contains operational updates and business highlights for the quarter. The presence of an Appendix 4C, which is a standard quarterly cash flow report required by the ASX Listing Rules, further confirms this is a quarterly financial report. The document is comprehensive, with substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or a brief summary, nor is it a full annual report or earnings release. Therefore, the correct classification is Interim / Quarterly Report (IR). Q3 2026
2026-04-28 English
Director Appointments 3 pages 261.0KB
Board/Management Information Classification · 90% confidence The document is a company announcement detailing the appointment of two new Non-Executive Directors to the Board, including their backgrounds and the strategic rationale. This is clearly a Board/Management Information update regarding changes in senior management. Therefore, it falls under ‘Board/Management Information’ (MANG).
2026-04-27 English
Initial Director's Interest Notice - Dr David Fuller 2 pages 38.4KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3X "Initial Director's Interest Notice" under listing rule 3.19A.1, detailing a director’s personal interests in the company’s securities. This matches the definition of a Director’s Dealing report (insider transactions by company directors).
2026-04-27 English
Initial Director's Interest Notice - Michael Sistenich 2 pages 4.2KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3X 'Initial Director’s Interest Notice' disclosing a director’s relevant interests (or lack thereof) in company securities under listing rule 3.19A.1 and section 205G of the Corporations Act. This is a personal share transaction/interest disclosure by a director, matching the definition of Director’s Dealing (insider trades).
2026-04-27 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.